MORE►
Colossal
Colossal BioVault, located at Colossal Biosciences' headquarters in Dallas. [Photo: Colossal]
Dallas-Based Colossal and U.S. Fish and Wildlife Service Launch BioVault Initiative for Endangered Species
by Sandra Engelland | Jun 25, 2026
"By preserving the genetic blueprint of every endangered species in America, we're creating a living archive of Earth's biodiversity—a modern-day Noah's Ark built from DNA and a permanent genetic backup of our nation's most imperiled species," said Colossal Biosciences Co-Founder and CEO Ben Lamm.
by Quincy Preston and Sandra Engelland |
May 19, 2026
The Dallas biotech says the shell-less incubation platform could help revive species such as the South Island Giant Moa, whose massive eggs exceed the capacity of any living bird surrogate.
MORE►
by Lance Murray |
Nov 13, 2025
The Bolson tortoise is North America's largest and rarest tortoise species. Its population has grown from 23 adults to over 800 individuals through captive breeding, with over 150 juveniles released since 2021 showing 80%+ survival rates.
MORE►
by Glenn Hunter |
Apr 30, 2025
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
MORE►
Carter Inc. during a move at Pegasus Park in Dallas. [Photo: Carter Inc.]
From Research Labs to Operating Rooms, Dallas-Based Carter Inc. Packs Up Success for Critical Relocations
by Nicole Ward, DRC Data Journalist | Aug 14, 2024
Carter Inc. aims to be the first call for both corporate and high-stakes biotech relocations, working to keep transitions smooth and operations on track.
MORE►
by Glenn Hunter |
May 2, 2024
Dallas Innovates, the Dallas Regional Chamber, and Dallas AI have teamed up to launch the inaugural AI 75 list. The 2024 program honors the most significant people in AI in DFW in seven categories—the visionaries, creators, and influencers you need to know.
MORE►
by Lance Murray |
Apr 17, 2024
Colossal Biosciences’ academic investments include partnerships with Stockholm University, the University of Potsdam, the University of California Santa Cruz, the University of Alaska, McMaster University, University of Copenhagen, and Rowan University, among others.
MORE►
by David Seeley |
Nov 27, 2023
“The dodo is the symbol of man-caused extinction,” Dallas-based Colossal Co-Founder and CEO Ben Lamm said last January. “It’s only fitting that Colossal works to reverse that.” The newly announced partnership with the MWF could help advance Colossal's efforts by restoring the dodo's natural habitat.
MORE►
Fatu in front and Najin in back are the last two known northern white rhinos alive on the planet. They live at Ol Pejeta conservancy in Kenya. [Photo: Ami Vitale]
Edge of Extinction: Pioneering Texas Biotech Colossal and BioRescue Race to Save the Northern White Rhino Species
by Quincy Preston and Lance Murray | Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
by Dallas Innovates | Staff Report |
Mar 1, 2023
Dallas-Fort Worth is well known for its tech expertise. Now it being recognized as the place where technology meets life science—a convergence that’s driving rapid growth in the biotech ecosystem....
MORE►
by Lance Murray |
Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District.
Here's a full list of winners and finalists.
MORE►
by Lance Murray |
Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas.
Finalists will be recognized in the January/February issue of D CEO magazine and online at DallasInnovates.com. Winners will be revealed at an exclusive awards event in January.
MORE►
Dr. Venu Varanasi, an associate professor and lab director at UT Arlington, won the pitch competition. [Photo: UT Arlington]
UT Arlington Researcher Takes Home Pitch Competition Prize for Bone Regeneration Work
by Kevin Cummings | Sep 26, 2022
After a rigorous process, the top six applications to the Tech Transfer Office Showcase at BioNTX's iC3 life science summit were invited to pitch live at BioNTX's life science summit. Industry experts rated, graded, and discussed the technologies prior to the pitches
"We want to cultivate technologies that are coming out of the university ecosystem here—and we want them to stay here," said Chad Ronholdt, managing director at NVB Ventures.
MORE►
by Quincy Preston and David Seeley |
Mar 9, 2022
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid.
With a total raise of $75 million to date, the startup aims to
have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE►
by David Seeley |
Dec 3, 2021
The Eos—a refrigerator-sized green energy solution powered by machine intelligence—captures and sequesters carbon from the atmosphere using algae. Hypergiant founder Ben Lamm, who's trying to bring back the woolly mammoth with his new startup Colossal, looks back at the development of Eos, and what it could mean for the world.
MORE►
